Real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web questionnaire survey
Modern Rheumatology · 2024
DOI: 10.1093/mr/roae034 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Modern Rheumatology, 2024. Verfasst von Yoshiyuki Abe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Takayasu Arteritis, Giant Cell Arteritis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Objectives
The aim is to access the real-world clinical management of physicians who treat Takayasu arteritis (TAK) and giant cell arteritis (GCA) after the publication of the Japanese Circulation Society (JCS) 2017 Guidelines for the Management of Vasculitis Syndrome.
Methods
This descriptive, cross-sectional study utilized self-administered electronic questionnaires, which were answered in February 2022 by physicians treating TAK or GCA and registered with Macromill Inc.
Results
The 329 survey respondents were enrolled. The 2017 JCS Guidelines were the most commonly referenced information source for resolving clinical questions, accessed by 70% of respondents. Ophthalmoscopy was performed in only 50% of patients with TAK and in 70% for GCA. The median percentages of patients who underwent 18F-fluorodeoxyglucose-positron emission tomography/computed tomography for TAK and GCA patients were 23% and 20% at diagnosis, respectively, and 10% each at follow-up within 12 months. Tocilizumab was the most frequently used medication in combination with glucocorticoids for both TAK and GCA, especially in remission induction therapy for relapsed patients.
Conclusions
The majority of physicians treating TAK and GCA referred to the 2017 JCS guidelines. This report clarified the current clinical practice for large vessel vasculitis in Japan, providing information for the next revision of the guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan.
- Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Wakayama, Japan.
- Department of Nephrology, Rheumatology, Endocrinology, and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
- Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.
ORCID-Profile: Yoshiyuki Abe, Takahiko Sugihara, Haruhito A Uchida, Yoshikazu Nakaoka, Masayoshi Harigai, Naoto Tamura
Zitieren
APA
Abe, Y., Fujii, T., Miyawaki, Y., Sugihara, T., Uchida, H. A., Maejima, Y., Watanabe, Y., Hashimoto, T., Miyamae, T., Nakaoka, Y., Harigai, M., & Tamura, N. (2024). Real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web questionnaire survey. Modern Rheumatology. https://doi.org/10.1093/mr/roae034
Vancouver
Abe Y, Fujii T, Miyawaki Y, Sugihara T, Uchida HA, Maejima Y, et al. Real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web questionnaire survey. Modern Rheumatology. 2024. doi:10.1093/mr/roae034
BibTeX
@article{Abe2024,
author = {Abe, Yoshiyuki and Fujii, Takao and Miyawaki, Yoshia and Sugihara, Takahiko and Uchida, Haruhito A and Maejima, Yasuhiro and Watanabe, Yoshiko and Hashimoto, Takuya and Miyamae, Takako and Nakaoka, Yoshikazu and Harigai, Masayoshi and Tamura, Naoto},
title = {Real-world clinical decisions of physicians in the management of Takayasu arteritis and giant cell arteritis in Japan: A cross-sectional web questionnaire survey},
journal = {Modern Rheumatology},
year = {2024},
doi = {10.1093/mr/roae034}
}
EUVIMED